Correction: Molecular resistance mechanisms to newly approved antibiotics (2017–2025) in WHO priority pathogens
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsClostridium difficile and Clostridium perfringens research · Veterinary medicine and infectious diseases · Phenothiazines and Benzothiazines Synthesis and Activities
The hierarchical structure of sections and sub-sections were incorrectly formatted in the final version of the article.
There was a mistake in Table 2 as published. In line 2 of the table, regarding “Cefepime and enmetazobactam” antibiotic, the column “Main use” reports “HABP, cUTIs, and cIAIs”. The corrected Table 2 appears below, where “cIAIs” has been removed for that drug.
The original version of this article has been updated.